Berenberg Bank set a €95.60 ($113.81) price target on Fresenius Medical Care AG & Co. KGAA (ETR:FME) in a report released on Wednesday. The brokerage currently has a buy rating on the stock.

Several other equities analysts have also recently commented on FME. Deutsche Bank set a €84.00 ($100.00) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a neutral rating in a research note on Tuesday, August 8th. J P Morgan Chase & Co set a €95.10 ($113.21) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a buy rating in a research note on Tuesday, August 8th. Goldman Sachs Group set a €97.00 ($115.48) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a buy rating in a research note on Tuesday, August 8th. Citigroup set a €92.00 ($109.52) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a buy rating in a research note on Tuesday, August 8th. Finally, Independent Research set a €88.00 ($104.76) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a neutral rating in a research note on Tuesday, August 8th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and ten have issued a buy rating to the company. Fresenius Medical Care AG & Co. KGAA currently has a consensus rating of Hold and an average target price of €89.06 ($106.03).

Fresenius Medical Care AG & Co. KGAA (ETR:FME) opened at €87.30 ($103.93) on Wednesday. Fresenius Medical Care AG & Co. KGAA has a 12 month low of €73.60 ($87.62) and a 12 month high of €89.22 ($106.21).

COPYRIGHT VIOLATION WARNING: This piece was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/12/09/fresenius-medical-care-ag-95-60-price-target-by-berenberg-bank-analysts.html.

About Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGAA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGAA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGAA and related companies with MarketBeat.com's FREE daily email newsletter.